Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Orl-Head and Neck Nursing : Official Journal of the Society of Otorhinolaryngology and Head-Neck Nurses|September 24, 2004
Recurrent epistaxis and integrated nursing management: a case reportPratima Poudel Acharya
Health Care for Women International|January 27, 2004
Birth outcomes across ethnic groups of women in NepalPratima Poudel Acharya, Fiona Alpass
The British Journal of Dermatology|December 18, 2025
P18 ZMPSTE24 variant with the lethal phenotype of restrictive dermopathyPratima Poudel, Celia Moss, Malobi Ogboli
The British Journal of Dermatology|December 18, 2025
P11 Prolonged diagnostic journey in infantile bullous pemphigoidPratima Poudel, Celia Moss, Malobi Ogboli
Methods in Molecular Biology (Clifton, N.J.)|March 5, 2024
Detection of MicroRNAs Using Synthetic Toehold Switch in Mammalian CellsYuwen Zhao, Pratima Poudel, Shue Wang
The British Journal of Dermatology|December 18, 2025
P15 Scabies in pediatric population in Nepal: a study from tertiary-care referral children's hospitalPratima Poudel, Niraj Parajuli, Pritam Pandey, et al.
Frontiers in Medical Technology|February 20, 2026
Drug-loaded nanoparticles reduced platelet aggregation and blood coagulationSarah Majin, Afrida Malik, Pratima Poudel, et al.
The British Journal of Dermatology|December 18, 2025
O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trialMaria L Bageta, Pablo López Balboa, Matt Bursnall, et al.
BMJ Open|May 21, 2025
Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extensionMaria L Bageta, Pablo López-Balboa, Munyaradzi Dimairo, et al.
Eclinicalmedicine|November 3, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phaseMaria L Bageta, Pablo Lopez-Balboa, Matt Bursnall, et al.
Pageof 2